论文部分内容阅读
本文观察了46例预后不良的急性髓系白血病 (AML)应用以胺苯吖啶(m-AMSA)为基础的联合方案化疗的疗效和毒副作用。病人的中位年龄为55岁(其中≥60岁20例,<60岁26例);男性28例,女性18例。按FAB分型:AUL2例,M_0 1例,M_1 8例,M_2 10例,M_3 1例、M_4 17例、M_5 2例、M_6 2例、M,2例,不能分型的1例。其中第一组(17例,对DA为
In this paper, 46 patients with poor prognosis of acute myeloid leukemia (AML) application of amine benzene acridine (m-AMSA) -based combination chemotherapy and efficacy of the side effects. The median age of patients was 55 years (20 ≥ 60 years, 26 cases <60 years old); 28 males and 18 females. According to FAB classification, there were 1 case of AUL, 2 cases of M_0, 8 cases of M_1, 10 cases of M_2, 1 case of M_3, 17 cases of M_4, 2 cases of M_5, 2 cases of M_6, 2 cases of M and 2 cases unable to type. The first group (17 cases, for DA